Request SampleGlobal Oxycodone Hydrochloride Sales Market Report 2023
SKU ID : QYR-22285747 | Publishing Date : 02-Jan-2023 | No. of pages : 123
Market Analysis and Insights: Global Oxycodone Hydrochloride Market
Oxycodone hydrochloride is a white, odorless crystalline powder derived from the opium alkaloid, thebaine. Oxycodone hydrochloride dissolves in water (1 g in 6 to 7 mL) and is considered slightly soluble in alcohol (octanol water partition coefficient is 0.7).
Due to the COVID-19 pandemic, the global Oxycodone Hydrochloride market size is estimated to be worth US$ 396.3 million in 2022 and is forecast to a readjusted size of US$ 459.2 million by 2029 with a CAGR of 2.1% during the forecast period 2023-2029. Fully considering the economic change by this health crisis, Oxycodone Hydrochloride accounting for % of the Oxycodone Hydrochloride global market in 2022, is projected to value US$ million by 2029, growing at a revised % CAGR from 2023 to 2029. While Tablet segment is altered to an % CAGR throughout this forecast period.
USA keeps the dominant place in both the production and consumption. According to International Narcotics Control Board, USA takes about 78% oxycodone prescription share. Globally, oxycodone hydrochloride producers are concentrated in USA, France and UK. Leading players in oxycodone hydrochloride industry are Mallinckrodt, Purdue Pharma, Noramco(Johnson & Johnson), Siegfried and Macfarlan Smith, etc. The top 5 got about 80% market shares.
Global Oxycodone Hydrochloride Scope and Market Size
The global Oxycodone Hydrochloride market is segmented by company, region (country), type and application. Players, stakeholders, and other participants in the global Oxycodone Hydrochloride market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), type and application for the period 2018-2029.
Segment by Type
Oxycodone Hydrochloride
Others
Segment by Application
Tablet
Oral Solution
Oral Capsule
Intravenous Fluid
By Region
United States
Europe
China
Japan
Southeast Asia
India
Other Regions
By Company
Mallinckrodt
Purdue Pharma
Noramco(Johnson & Johnson)
Siegfried
Cepia-Sanofi
Macfarlan Smith
Chattem Chemicals(Sun Pharma)
Temad
Oxycodone hydrochloride is a white, odorless crystalline powder derived from the opium alkaloid, thebaine. Oxycodone hydrochloride dissolves in water (1 g in 6 to 7 mL) and is considered slightly soluble in alcohol (octanol water partition coefficient is 0.7).
Due to the COVID-19 pandemic, the global Oxycodone Hydrochloride market size is estimated to be worth US$ 396.3 million in 2022 and is forecast to a readjusted size of US$ 459.2 million by 2029 with a CAGR of 2.1% during the forecast period 2023-2029. Fully considering the economic change by this health crisis, Oxycodone Hydrochloride accounting for % of the Oxycodone Hydrochloride global market in 2022, is projected to value US$ million by 2029, growing at a revised % CAGR from 2023 to 2029. While Tablet segment is altered to an % CAGR throughout this forecast period.
USA keeps the dominant place in both the production and consumption. According to International Narcotics Control Board, USA takes about 78% oxycodone prescription share. Globally, oxycodone hydrochloride producers are concentrated in USA, France and UK. Leading players in oxycodone hydrochloride industry are Mallinckrodt, Purdue Pharma, Noramco(Johnson & Johnson), Siegfried and Macfarlan Smith, etc. The top 5 got about 80% market shares.
Global Oxycodone Hydrochloride Scope and Market Size
The global Oxycodone Hydrochloride market is segmented by company, region (country), type and application. Players, stakeholders, and other participants in the global Oxycodone Hydrochloride market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), type and application for the period 2018-2029.
Segment by Type
Oxycodone Hydrochloride
Others
Segment by Application
Tablet
Oral Solution
Oral Capsule
Intravenous Fluid
By Region
United States
Europe
China
Japan
Southeast Asia
India
Other Regions
By Company
Mallinckrodt
Purdue Pharma
Noramco(Johnson & Johnson)
Siegfried
Cepia-Sanofi
Macfarlan Smith
Chattem Chemicals(Sun Pharma)
Temad
Frequently Asked Questions
This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
- By product type
- By End User/Applications
- By Technology
- By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
24/7 Research Support
Phone: +1 (888) 690-5999 
